CH625123A5 - - Google Patents
Download PDFInfo
- Publication number
- CH625123A5 CH625123A5 CH1543576A CH1543576A CH625123A5 CH 625123 A5 CH625123 A5 CH 625123A5 CH 1543576 A CH1543576 A CH 1543576A CH 1543576 A CH1543576 A CH 1543576A CH 625123 A5 CH625123 A5 CH 625123A5
- Authority
- CH
- Switzerland
- Prior art keywords
- solution
- injection
- potassium
- ready
- water
- Prior art date
Links
- 239000000243 solution Substances 0.000 description 51
- 238000002347 injection Methods 0.000 description 40
- 239000007924 injection Substances 0.000 description 40
- PBKZPPIHUVSDNM-WNHSNXHDSA-N canrenoic acid Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)CCC(O)=O)[C@@H]4[C@@H]3C=CC2=C1 PBKZPPIHUVSDNM-WNHSNXHDSA-N 0.000 description 39
- 239000000872 buffer Substances 0.000 description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 239000008215 water for injection Substances 0.000 description 18
- 229960000206 potassium canrenoate Drugs 0.000 description 17
- 229960002823 canrenoic acid Drugs 0.000 description 16
- 239000000203 mixture Substances 0.000 description 13
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 12
- 239000003708 ampul Substances 0.000 description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 239000003513 alkali Substances 0.000 description 9
- 238000000354 decomposition reaction Methods 0.000 description 9
- HMEDEBAJARCKCT-UHFFFAOYSA-N azosemide Chemical compound C=1C=CSC=1CNC=1C=C(Cl)C(S(=O)(=O)N)=CC=1C1=NN=NN1 HMEDEBAJARCKCT-UHFFFAOYSA-N 0.000 description 7
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 7
- 229940086673 canrenoate Drugs 0.000 description 6
- 229960003883 furosemide Drugs 0.000 description 6
- 239000002934 diuretic Substances 0.000 description 5
- 230000001882 diuretic effect Effects 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 5
- 235000019798 tripotassium phosphate Nutrition 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940102223 injectable solution Drugs 0.000 description 2
- 229940097271 other diuretics in atc Drugs 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2556001A DE2556001C3 (de) | 1975-12-12 | 1975-12-12 | Spritzfertige injizierbare Lösungen mit einem Gehalt an Alkalicanrenoat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH625123A5 true CH625123A5 (cs) | 1981-09-15 |
Family
ID=5964213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1543576A CH625123A5 (cs) | 1975-12-12 | 1976-12-08 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4088759A (cs) |
| JP (1) | JPS5272811A (cs) |
| AT (1) | AT345465B (cs) |
| BE (1) | BE849282A (cs) |
| CA (1) | CA1062157A (cs) |
| CH (1) | CH625123A5 (cs) |
| DE (1) | DE2556001C3 (cs) |
| DK (1) | DK153441C (cs) |
| FI (1) | FI55442C (cs) |
| FR (1) | FR2334371A1 (cs) |
| GB (1) | GB1509477A (cs) |
| NL (1) | NL187517C (cs) |
| SE (1) | SE442587B (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2950832C2 (de) * | 1979-12-18 | 1983-03-17 | Hoechst Ag, 6000 Frankfurt | Spritzfertige injizierbare wäßrige Lösungen der Alkalisalze von Canrenoinsäure und Furosemid |
| DE4228926A1 (de) * | 1992-08-31 | 1994-03-03 | Boehringer Mannheim Gmbh | Spritzfertige Azosemid-Injektionslösungen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3276959A (en) * | 1963-08-08 | 1966-10-04 | Hefa G M B H | Stabilized steroid compositions |
| US3487152A (en) * | 1967-02-07 | 1969-12-30 | Hoffmann La Roche | Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances |
| DE2423550A1 (de) * | 1974-05-15 | 1975-11-27 | Boehringer Mannheim Gmbh | Pharmazeutisches praeparat |
-
1975
- 1975-12-12 DE DE2556001A patent/DE2556001C3/de not_active Expired
-
1976
- 1976-11-16 US US05/742,303 patent/US4088759A/en not_active Expired - Lifetime
- 1976-12-02 CA CA267,038A patent/CA1062157A/en not_active Expired
- 1976-12-06 DK DK547176A patent/DK153441C/da not_active IP Right Cessation
- 1976-12-07 GB GB50960/76A patent/GB1509477A/en not_active Expired
- 1976-12-08 CH CH1543576A patent/CH625123A5/de not_active IP Right Cessation
- 1976-12-09 SE SE7613849A patent/SE442587B/xx not_active IP Right Cessation
- 1976-12-10 AT AT916376A patent/AT345465B/de not_active IP Right Cessation
- 1976-12-10 JP JP51148644A patent/JPS5272811A/ja active Granted
- 1976-12-10 FR FR7637360A patent/FR2334371A1/fr active Granted
- 1976-12-10 BE BE173152A patent/BE849282A/xx not_active IP Right Cessation
- 1976-12-10 NL NLAANVRAGE7613750,A patent/NL187517C/xx not_active IP Right Cessation
- 1976-12-10 FI FI763564A patent/FI55442C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE2556001B2 (de) | 1979-04-12 |
| FR2334371A1 (fr) | 1977-07-08 |
| SE7613849L (sv) | 1977-06-13 |
| DK153441C (da) | 1988-11-21 |
| DK153441B (da) | 1988-07-18 |
| GB1509477A (en) | 1978-05-04 |
| BE849282A (fr) | 1977-06-10 |
| FI55442C (fi) | 1979-08-10 |
| FI763564A7 (cs) | 1977-06-13 |
| CA1062157A (en) | 1979-09-11 |
| ATA916376A (de) | 1978-01-15 |
| US4088759A (en) | 1978-05-09 |
| AU2043776A (en) | 1977-10-20 |
| FR2334371B1 (cs) | 1980-03-28 |
| SE442587B (sv) | 1986-01-20 |
| AT345465B (de) | 1978-09-25 |
| DE2556001A1 (de) | 1977-06-16 |
| NL187517B (nl) | 1991-06-03 |
| FI55442B (fi) | 1979-04-30 |
| DK547176A (da) | 1977-06-13 |
| NL187517C (nl) | 1991-11-01 |
| DE2556001C3 (de) | 1979-11-29 |
| NL7613750A (nl) | 1977-06-14 |
| JPS5517010B2 (cs) | 1980-05-08 |
| JPS5272811A (en) | 1977-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69305642T2 (de) | Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten | |
| DE4344824C1 (de) | Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung | |
| DE69104724T2 (de) | Florfenicol enthaltendes arzneimittel. | |
| DE69827357T2 (de) | Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung | |
| DE3042332A1 (de) | Waessrige nitroglycerinloesung | |
| DE2827027B2 (de) | Gefriergetrocknetes natives T -globulin-Präparat zur intravenösen Verabreichung | |
| EP0253226A1 (de) | Spritzfertige, wässrige, alkalische Injektionslösung von Torasemid und Verfahren zu ihrer Herstellung | |
| DE602005002495T2 (de) | Injizierbare Formulierung mit Natriumdiclofenac, Beta-Cyclodextrin und einem Polysorbat | |
| DE4010536C2 (cs) | ||
| DE60101979T2 (de) | Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel | |
| DE1053736B (de) | Verfahren zur Erhoehung der Loeslichkeit therapeutisch wirksamer Stoffe in Wasser | |
| CH625123A5 (cs) | ||
| DE2546474A1 (de) | Injizierbares pharmazeutisches thyroxinpraeparat und verfahren zu dessen herstellung | |
| DE1792448C3 (de) | Verfahren zur Herstellung von zur parenteralen Verabreichung geeigneten stabilen Lösungen von therapeutisch anwendbaren Benzodiazepinderivaten | |
| DE938502C (de) | Verfahren zur Herstellung einer kolloidalen Eisenzubereitung | |
| DE3509741A1 (de) | Orale dosierungsform von etoposid | |
| EP0108248B2 (de) | Lösungsvermittlerfreie, wässrige Nitroglycerinlösung | |
| EP0656777B1 (de) | Spritzfertige azosemid-injektionslösungen | |
| DE2209526A1 (de) | Coronarmittel in spezieller form sowie verfahren zu seiner herstellung | |
| DE2820992A1 (de) | Arzneimittel auf nitroimidazol-basis | |
| DE1617433C (de) | Verfahren zur Herstellung von 5,5 Diphenyl hydantoin Natrium Losungen fur Injektionszwecke | |
| DE2538678A1 (de) | Injizierbare loesungen | |
| DE2445401C3 (de) | Injizierbare, einphasige Zubereitung und Verfahren zu ihrer Herstellung | |
| DE2026864C (de) | 2-Äthyl- oder 2-Propylthioisonikotinsäureamid enthaltende InjektionsJösungen | |
| DE1955245A1 (de) | Intravenoese Loesung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |